Medipense announced this week its innovative RxPense medication management and remote monitoring device at the MedTech Conference, and demonstrated its integration with Hexoskin biometric shirts.
“I’m so proud to officially launch the RxPense Nova17, the birth of a new generation in medication dispensing, for those who struggle staying adherent to multiple medications” stated Terry Fagen, President and Founder of Medipense.
"Medipense has a unique solution for medication management, and we're glad they chose Hexoskin as a vital signs monitoring partner. Our companies share a common same vision for connected health and the future in healthcare" says Pierre-Alexandre Fournier, CEO of Hexoskin.
The MedTech Conference is in San Jose, California from September 25th to September 27th 2017.
Medipense is the inventor and manufacturer of RxPense®, an integrated, intelligent and connected medication therapy management and remote monitoring system designed for Seniors, Chronic Care Patients, Disabled Veterans, and those with complex medication regimens.
Hexoskin is the world leader in smart clothing for health monitoring. Hexoskin smart shirts are used by thousands of athletes, trainers, and health professionals all over the world, and provide a new, convenient way to understand human health in real-life environments. In addition to serving its clients in sports science and health research, Hexoskin is a supplier of smart clothing for aerospace and military organizations in many countries, including the United States.
Hexoskin is attending the AI in Healthcare Summit in San Francisco this week to present its connected health platform and healthcare AI architecture on Monday, June 26th.
The current hospital system has been built around the treatment of acute illness: emergencies, injuries, infections, etc. Chronic diseases are changing healthcare, and we are now entering a future in which care delivery is becoming decentralized, where communication between health professionals and patients is being facilitated by technology, leading to many potential advancements in prevention, treatment of chronic illness, and much more.
In his talk, Hexoskin's CEO Pierre-Alexandre Fournier discusses the specific tools enabling these advancements, what challenges exist in using health data for AI, and how healthcare professionals can leverage these new technologies to improve the quality of life for chronically ill patients.
The Hexoskin software research platform is designed to generate continuous health data for the development of Artificial Intelligence (machine learning) algorithms for chronic diseases management. Hexoskin also offers AI and data science services to healthcare and pharma companies.
Hexoskin is the world leader in smart clothing and body sensing technologies. The company has announced last year it will equip the International Space Station (ISS) with a bio-monitoring system for astronauts in collaboration with NASA and the Canadian Space Agency.
The Montreal Heart Institute is currently completing a clinical trial with Hexoskin biometric shirts with angina patients undergoing therapy. One of the goals of the study is to develop a new vitality index using Hexoskin biometric shirts to assess angina and to monitor the rehabilitation of cardiac patients.
Hexoskin is the world leader in smart clothing for health monitoring. Hexoskin smart shirts are used by space and defense agencies, sports scientists, and thousands of health professionals and health researchers all over the world. The Hexoskin connected platform provides a new, convenient way to understand human health in real-life environments. For more information, write us at firstname.lastname@example.org, and visit www.hexoskin.com and @Hexoskin on Twitter.
CAUTION - Hexoskin products and services are not intended, and should not be used to investigate, diagnose, monitor, treat or prevent disease or other medical conditions nor to provide information for medical or diagnostic purposes.